Acquired Resistance to Selective Estrogen Receptor Modulators (SERMs) in Clinical Practice (Tamoxifen & Raloxifene) by Selection Pressure in Breast Cancer Cell Populations
Steroids - United States
doi 10.1016/j.steroids.2014.06.002
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2014
Authors
Publisher
Elsevier BV